These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15543319)

  • 1. Effects of heparin and low-molecular-weight heparins on bone mechanical properties in rats.
    Folwarczna J; Janiec W; Sliwiński L
    Thromb Haemost; 2004 Nov; 92(5):940-6. PubMed ID: 15543319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nadroparin on bone histomorphometric parameters in rats.
    Folwarczna J; Janiec W; Barej M; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I
    Pol J Pharmacol; 2004; 56(3):337-43. PubMed ID: 15215564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enoxaparin on histomorphometric parameters of bones in rats.
    Folwarczna J; Janiec W; Gawor M; Pytlik M; Kaczmarczyk-Sedlak I; Nowińska B
    Pol J Pharmacol; 2004; 56(4):451-7. PubMed ID: 15520500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low molecular weight heparins and unfractionated heparin on viability of human umbilical vein endothelial cells.
    Guler T; Polat ZA; Yayci E; Atacag T; Cetin A
    Arch Gynecol Obstet; 2013 Feb; 287(2):217-22. PubMed ID: 22987257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia.
    Pytlik M; Folwarczna J; Janiec W
    Calcif Tissue Int; 2004 Sep; 75(3):225-30. PubMed ID: 15164147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium.
    Dogan OT; Polat ZA; Karahan O; Epozturk K; Altun A; Akkurt I; Cetin A
    Thromb Res; 2011 Oct; 128(4):e29-32. PubMed ID: 21605890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat.
    Abdel-Salam OM; Baiuomy AR; Ameen A; Hassan NS
    Pharmacol Res; 2005 Jan; 51(1):59-67. PubMed ID: 15519536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose tacrolimus coadministered with raloxifene on the skeletal system in male rats.
    Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik M; Nowińska B; Cegieła U; Sliwiński L; Janiec W; Trzeciak H; Trzeciak HI
    Acta Pol Pharm; 2009; 66(2):207-12. PubMed ID: 19719057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro.
    Folwarczna J; Sliwiński L; Janiec W; Pikul M
    Pharmacol Rep; 2005; 57(5):635-45. PubMed ID: 16227647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism).
    Collignon F; Frydman A; Caplain H; Ozoux ML; Le Roux Y; Bouthier J; Thébault JJ
    Thromb Haemost; 1995 Apr; 73(4):630-40. PubMed ID: 7495071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
    Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.
    Sliwiński L; Janiec W; Pytlik M; Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik W; Cegieła U; Nowińska B
    Pol J Pharmacol; 2004; 56(6):817-24. PubMed ID: 15662095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.
    Wawrzyńska L; Tomkowski WZ; Przedlacki J; Hajduk B; Torbicki A
    Pathophysiol Haemost Thromb; 2003; 33(2):64-7. PubMed ID: 14624046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous factor Xa and IIa formation and on thrombelastometry profiles.
    Cvirn G; Wagner T; Juergens G; Koestenberger M
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):71-7. PubMed ID: 20339323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood.
    Cvirn G; Hoerl G; Tafeit E; Heinl N; Wodrig K; Wagner T; Koestenberger M; Juergens G
    Neonatology; 2011; 100(1):23-31. PubMed ID: 21150227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and low molecular weight heparins do not modify red blood cell aggregability in vitro.
    Martínez M; Vaya A; López-Camacho C; Coll-Sangrona E; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2000; 23(1):67-70. PubMed ID: 11214715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.
    Bai W; Zhang X; Sun S; Wang Q; Li C; Zhang X; Zhao A
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):683. PubMed ID: 34620101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ; Shi XB; Yang JG; Hu DY
    Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast growth inhibition by unfractionated heparin and by low molecular weight heparins: an in-vitro investigation.
    Kock HJ; Handschin AE
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):251-5. PubMed ID: 12361203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.
    Rydzewska-Rosolowska A; Borawski J; Mysliwiec M
    Adv Med Sci; 2009; 54(2):199-202. PubMed ID: 19758969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.